Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Pediatr Gastroenterol Nutr ; 74(3): 320-327, 2022 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-34984985

RESUMO

ABSTRACT: Incidental liver lesions are identified in children without underlying liver disease or increased risk of hepatic malignancy in childhood. Clinical and imaging evaluation of incidental liver lesions can be complex and may require a multidisciplinary approach. This review aims to summarize the diagnostic process and follow-up of incidental liver lesions based on review of the literature, use of state-of-the-art imaging, and our institutional experience. Age at presentation, gender, alpha fetoprotein levels, tumor size, and imaging characteristics should all be taken into consideration to optimize diagnosis process. Some lesions, such as simple liver cyst, infantile hemangioma, focal nodular hyperplasia (FNH), and focal fatty lesions, have specific imaging characteristics. Recently, contrast-enhanced ultrasound (CEUS) was Food and Drug Administration (FDA)-approved for the evaluation of pediatric liver lesions. CEUS is most specific in lesions smaller than 3 cm and is most useful in the diagnosis of infantile hemangioma, FNH, and focal fatty lesions. The use of hepatobiliary contrast in MRI increases specificity in the diagnosis of FNH. Recently, lesion characteristics in MRI were found to correlate with subtypes of hepatocellular adenomas and associated risk for hemorrhage and malignant transformation. Biopsy should be considered when there are no specific imaging characteristics of a benign lesion. Surveillance with imaging and alpha fetoprotein (AFP) should be performed to confirm the stability of lesions when the diagnosis cannot be determined, and whenever biopsy is not feasible.


Assuntos
Hiperplasia Nodular Focal do Fígado , Hemangioma , Neoplasias Hepáticas , Criança , Meios de Contraste , Diagnóstico Diferencial , Hiperplasia Nodular Focal do Fígado/diagnóstico por imagem , Hiperplasia Nodular Focal do Fígado/patologia , Seguimentos , Hemangioma/diagnóstico por imagem , Hemangioma/patologia , Humanos , Fígado/patologia , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/patologia , Imageamento por Ressonância Magnética/métodos , Sensibilidade e Especificidade , alfa-Fetoproteínas
3.
J Vasc Surg Venous Lymphat Disord ; 5(4): 587-595, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28624001

RESUMO

OBJECTIVE: A dearth of information exists in the literature regarding current practice in the management of Klippel-Trénaunay syndrome (KTS), a rare condition. We review and describe the etiology, diagnosis, and treatment of KTS. METHODS: Relevant data were synthesized from a Medline review using a combination of the keyterms "Klippel" and "Trénaunay." The majority of hits described singular case reports and were subsequently excluded. The remaining papers were then reviewed and included on the basis of the quality of evidence and the authors' discretion. CONCLUSIONS: KTS is characterized by a clinical triad of extremity varicosities, cutaneous vascular malformations, and hypertrophy of soft tissues and long bones. The diagnosis is clinically supplemented with magnetic resonance imaging and computed tomography. Although this syndrome is associated with significant comorbidities, such as pain, edema, ulcerations, and pruritus, it is rarely the cause of death. The backbone of treatment is nonoperative in nature but should be supplemented with minimally invasive, endovascular, and rarely open surgical procedures for refractory cases.


Assuntos
Síndrome de Klippel-Trenaunay-Weber/diagnóstico , Imageamento por Ressonância Magnética , Tomografia Computadorizada por Raios X , Diagnóstico Diferencial , Humanos , Hipertrofia/diagnóstico , Síndrome de Klippel-Trenaunay-Weber/etiologia , Síndrome de Klippel-Trenaunay-Weber/terapia , Resultado do Tratamento , Varizes/diagnóstico , Procedimentos Cirúrgicos Vasculares/métodos
4.
J Am Coll Radiol ; 13(3): 265-73, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26944037

RESUMO

Management of primary and secondary hepatic malignancy is a complex problem. Achieving optimal care for this challenging population often requires the involvement of multiple medical and surgical disciplines. Because of the wide variety of potential therapies, treatment protocols for various malignancies continue to evolve. Consequently, development of appropriate therapeutic algorithms necessitates consideration of medical options, such as systemic chemotherapy; surgical options, such as resection or transplantation; and loco-regional therapies, such as thermal ablation and transarterial embolization techniques. This article provides a review of treatment strategies for the three most common subtypes of hepatic malignancy treated with loco-regional therapies: hepatocellular carcinoma, neuroendocrine metastases, and colorectal metastases. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.


Assuntos
Quimioembolização Terapêutica/normas , Quimiorradioterapia/normas , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/terapia , Guias de Prática Clínica como Assunto , Radiologia/normas , Medicina Baseada em Evidências , Humanos , Sociedades Médicas , Resultado do Tratamento , Estados Unidos
7.
J Vasc Interv Radiol ; 23(11): 1397-402, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23101912

RESUMO

Image-guided drainage of abscesses and fluid collections is a valuable tool in the treatment of pediatric patients. It may obviate surgery or optimize the child's clinical condition for subsequent surgery. Compared with adults, several differences exist in terms of etiology, risks (especially radiation exposure), preprocedural imaging and planning, technical considerations, support issues such as sedation, and complications. Knowledge of these differences is important in the planning and treatment of these patients. In addition, a quality improvement plan can be used to assess practice performance.


Assuntos
Abscesso/terapia , Drenagem/normas , Pediatria/normas , Melhoria de Qualidade/normas , Radiografia Intervencionista/normas , Abscesso/diagnóstico por imagem , Fatores Etários , Anestesia/normas , Criança , Técnica Delphi , Drenagem/efeitos adversos , Drenagem/métodos , Medicina Baseada em Evidências/normas , Humanos , Hipnóticos e Sedativos/uso terapêutico , Proteção Radiológica/normas , Radiografia Intervencionista/efeitos adversos , Fatores de Risco
9.
J Pediatr Hematol Oncol ; 29(3): 166-72, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17356396

RESUMO

BACKGROUND: The clinical course of Epstein-Barr virus (EBV)-associated smooth muscle tumors is variable and there are no reports in patients with mixed T-cell chimerism after bone marrow transplantation (BMT). OBSERVATIONS: A child with X-linked severe combined immunodeficiency disease developed multiple renal and pulmonary leiomyomata 8 years after haploidentical BMT. Epstein-Barr viral DNA was detectable in the blood and in situ hybridization for EBV-encoded RNAs was positive in the tumor. The tumors have been radiographically stable, chimerism remains mixed, and plasma EBV DNA has been repeatedly negative for over 2 years after donor lymphocyte infusion. CONCLUSIONS: EBV-associated smooth muscle tumors may occur in patients who are partially reconstituted after BMT for severe combined immunodeficiency and may not require surgery or chemotherapy.


Assuntos
Transplante de Medula Óssea/efeitos adversos , Infecções por Vírus Epstein-Barr/complicações , Neoplasias Renais/diagnóstico , Leiomiomatose/patologia , Neoplasias Pulmonares/diagnóstico , Imunodeficiência Combinada Severa/terapia , Linfócitos T/patologia , Transplante de Medula Óssea/imunologia , Criança , Quimerismo , Infecções por Vírus Epstein-Barr/patologia , Humanos , Neoplasias Renais/virologia , Leiomiomatose/virologia , Neoplasias Pulmonares/virologia , Masculino , Sensibilidade e Especificidade , Imunodeficiência Combinada Severa/imunologia , Imunodeficiência Combinada Severa/virologia , Linfócitos T/virologia , Tomografia Computadorizada por Raios X/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA